Adam Wysokiński, Monika Talarowska, Agata Orzechowska, Krzysztof Zboralski, Piotr Gałecki, Antoni Florkowski
Current trends in pharmacological treatment of schizophrenia presented on the XIV World Congress of Psychiatry  5-9
Summary
The authors present the summary of current trends in the pharmacological treatment of schizophrenia presented during the XIV World Congress of Psychiatry (Prague, Czech Republic, 19-25 September 2008). The results of studies presented during the Congress, recommendations and new trends may be divided into two groups of actions: (1) aimed at increasing patients' compliance and adherence; and (2) aimed at promoting depot antipsychotics. The problem of the metabolic syndrome was also stressed as it remains a significant clinical complication of the treatment with antipsychotics, particularly with atypical ones. Moreover, it was also emphasized that clinical tools used to evaluate treatment efficacy should include scales which evaluate quality of life, for example SWN (Subjective Well-being under Neuroleptics) scale.